Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population | Zendy

Tracey G. Simon | Zendy; AnnSofi Duberg | Zendy; Soo Aleman | Zendy; Hannes Hagström | Zendy; Long H. Nguyen | Zendy; Hamed Khalili | Zendy; Raymond T. Chung | Zendy; Jonas F. Ludvigsson | Zendy

Open Access

Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population

Author(s) -

Tracey G. Simon,

AnnSofi Duberg,

Soo Aleman,

Hannes Hagström,

Long H. Nguyen,

Hamed Khalili,

Raymond T. Chung,

Jonas F. Ludvigsson

Publication year - 2019

Publication title -

annals of internal medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.839

H-Index - 390

eISSN - 1539-3704

pISSN - 0003-4819

DOI - 10.7326/m18-2753

Subject(s) - medicine , hepatocellular carcinoma , statin , hazard ratio , population , cumulative incidence , incidence (geometry) , cohort study , gastroenterology , prospective cohort study , hepatitis c , cohort , lower risk , confidence interval , physics , environmental health , optics

Whether statin type influences hepatocellular carcinoma (HCC) incidence or mortality in chronic hepatitis B or C virus infection is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research